Avandamet Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

avandamet

smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).

AVANDIA TABLET Καναδάς - Αγγλικά - Health Canada

avandia tablet

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 2mg - rosiglitazone (rosiglitazone maleate) 2mg - thiazolidinediones

AVANDIA TABLET Καναδάς - Αγγλικά - Health Canada

avandia tablet

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 4mg - rosiglitazone (rosiglitazone maleate) 4mg - thiazolidinediones

AVANDIA TABLET Καναδάς - Αγγλικά - Health Canada

avandia tablet

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 8mg - rosiglitazone (rosiglitazone maleate) 8mg - thiazolidinediones

AVANDAMET TABLET Καναδάς - Αγγλικά - Health Canada

avandamet tablet

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 1mg; 500mg - rosiglitazone (rosiglitazone maleate) 1mg; metformin hydrochloride 500mg - biguanides

AVANDAMET TABLET Καναδάς - Αγγλικά - Health Canada

avandamet tablet

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 500mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 500mg - biguanides